Publication Information

{'id': 'https://openalex.org/W2162495586', 'doi': 'https://doi.org/10.3109/09546630903559814', 'title': 'Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: A case series', 'display_name': 'Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: A case series', 'publication_year': 2010, 'publication_date': '2010-06-05', 'ids': {'openalex': 'https://openalex.org/W2162495586', 'doi': 'https://doi.org/10.3109/09546630903559814', 'mag': '2162495586', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20524874'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.3109/09546630903559814', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S21432770', 'display_name': 'Journal of Dermatological Treatment', 'issn_l': '0954-6634', 'issn': ['0954-6634', '1471-1753'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320449', 'host_organization_name': 'Informa', 'host_organization_lineage': ['https://openalex.org/P4310320449'], 'host_organization_lineage_names': ['Informa'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5031300337', 'display_name': 'Tina Bhutani', 'orcid': 'https://orcid.org/0000-0001-8187-1024'}, 'institutions': [{'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Tina Bhutani', 'raw_affiliation_strings': ['University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California, USA'], 'affiliations': [{'raw_affiliation_string': 'University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California, USA', 'institution_ids': ['https://openalex.org/I180670191']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5102727788', 'display_name': 'John Koo', 'orcid': 'https://orcid.org/0009-0004-1005-5221'}, 'institutions': [{'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Koo', 'raw_affiliation_strings': ['University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California, USA'], 'affiliations': [{'raw_affiliation_string': 'University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California, USA', 'institution_ids': ['https://openalex.org/I180670191']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5031300337'], 'corresponding_institution_ids': ['https://openalex.org/I180670191'], 'apc_list': {'value': 0, 'currency': 'USD', 'value_usd': 0, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.799, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 18, 'citation_normalized_percentile': {'value': 0.818763, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 88, 'max': 89}, 'biblio': {'volume': '22', 'issue': '2', 'first_page': '75', 'last_page': '78'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10837', 'display_name': 'Dermatology and Skin Diseases', 'score': 0.9928, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10051', 'display_name': 'Asthma and respiratory diseases', 'score': 0.97, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.98091793}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.9807639}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9387952}, {'id': 'https://openalex.org/C2780564577', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Psoriasis', 'level': 2, 'score': 0.84675026}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.5141659}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.41525197}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.330433}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.2754298}], 'mesh': [{'descriptor_ui': 'D000893', 'descriptor_name': 'Anti-Inflammatory Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000068879', 'descriptor_name': 'Adalimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000893', 'descriptor_name': 'Anti-Inflammatory Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018450', 'descriptor_name': 'Disease Progression', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.3109/09546630903559814', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S21432770', 'display_name': 'Journal of Dermatological Treatment', 'issn_l': '0954-6634', 'issn': ['0954-6634', '1471-1753'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320449', 'host_organization_name': 'Informa', 'host_organization_lineage': ['https://openalex.org/P4310320449'], 'host_organization_lineage_names': ['Informa'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20524874', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.76, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 6, 'referenced_works': ['https://openalex.org/W1970401331', 'https://openalex.org/W2063627867', 'https://openalex.org/W2081479967', 'https://openalex.org/W2122115277', 'https://openalex.org/W2164533070', 'https://openalex.org/W2742484040'], 'related_works': ['https://openalex.org/W2980843199', 'https://openalex.org/W2809810071', 'https://openalex.org/W2318799791', 'https://openalex.org/W2236197927', 'https://openalex.org/W2162495586', 'https://openalex.org/W2116752853', 'https://openalex.org/W2075153701', 'https://openalex.org/W2075066605', 'https://openalex.org/W2059101060', 'https://openalex.org/W2013794712'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Etanercept': [2], 'and': [3, 155, 168], 'adalimumab': [4, 26, 89], 'are': [5], 'the': [6, 21, 60, 79, 83, 105], 'most': [7], 'widely': [8], 'used': [9], 'biologic': [10], 'agents': [11], 'for': [12, 35, 157], 'psoriasis': [13, 62, 93], 'today.': [14], 'Large': [15], 'phase': [16], 'III': [17], 'trials': [18], 'have': [19, 128], 'elucidated': [20], 'much': [22], 'higher': [23], 'efficacy': [24, 86, 107], 'of': [25, 44, 78, 88, 135, 143], 'over': [27, 90], 'etanercept;': [28], 'however,': [29], 'no': [30, 140], 'head-to-head': [31], 'comparison': [32], 'data': [33], 'exist': [34], 'these': [36, 110], 'two': [37, 111], 'medications.': [38], 'Objective:': [39], 'We': [40], 'report': [41, 72], 'four': [42, 58], 'cases': [43], 'patients': [45, 94, 126], 'well': [46], 'controlled': [47], 'with': [48, 99, 130], 'Enbrel': [49], 'who': [50, 127], 'flared': [51], 'when': [52, 64], 'switched': [53, 65], 'to': [54, 67, 75, 145], 'adalimumab.': [55, 102], 'In': [56], 'all': [57], 'cases,': [59], "patient's": [61], 'improved': [63], 'back': [66], 'etanercept.': [68], 'Conclusion:': [69], 'This': [70], 'brief': [71], 'is': [73], 'intended': [74], 'alert': [76], 'clinicians': [77], 'possibility': [80], 'that,': [81], 'despite': [82, 104], 'well-known': [84], 'average': [85], 'advantage': [87], 'etanercept,': [91], 'some': [92], 'experience': [95], 'better': [96], 'clinical': [97, 152], 'outcome': [98], 'etanercept': [100, 121], 'than': [101], 'Therefore,': [103], 'general': [106], 'difference': [108], 'between': [109], 'TNF': [112], 'inhibitors,': [113], 'it': [114], 'may': [115], 'be': [116], 'worth': [117], 'keeping': [118], 'in': [119, 125], 'mind': [120], 'as': [122], 'an': [123], 'option': [124], 'failed': [129], 'adalimumab.Key': [131], 'words::': [132], 'adalimumabEnbreletanerceptHumirapsoriasis': [133], 'Declaration': [134], 'interest:': [136], 'Dr': [137, 147], 'Bhutani': [138], 'has': [139, 149], 'financial': [141], 'conflicts': [142], 'interest': [144], 'report.': [146], 'Koo': [148], 'been': [150], 'a': [151], 'researcher,': [153], 'consultant,': [154], 'speaker': [156], 'Abbott,': [158], 'Allergan,': [159], 'Amgen,': [160], 'Astellas,': [161], 'Galderma,': [162], 'Genentech,': [163], 'JSJ,': [164], 'Photomedex,': [165], 'Roche,': [166], 'Warner-Chilcott,': [167], 'Teikoku.': [169]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2162495586', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-08T06:08:03.910412', 'created_date': '2016-06-24'}